← Leaderboards
Zahi A. Fayad
Mount Sinai School Of Medicine Of Nyu
$38,968,445
Attributed
$49,374,571
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$78,219,782 · 20
By mechanism
R01$41,723,622 · 12
P01$36,496,160 · 8
Top collaborators
- Nelly Alia-Klein4 shared
- Rita Z Goldstein4 shared
- David H Adams3 shared
- Joren C Madsen3 shared
- Marc Miller3 shared
- Carlos PãRez-Medina3 shared
- Maria Giovanna Trivieri3 shared
- Michael E Farkouh2 shared
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageAtherosclerosisMagnetic Resonance ImagingInflammationPositron-Emission TomographyArterial Fatty StreakMacrophageIn VivoBaseProgramsEventHigh RiskInflammatoryMyocardial InfarctionImaging ModalityCardiovascular DiseasesCellsCardiovascular SystemStrokeImaging TechniquesLinkResearch PersonnelFluorodeoxyglucose Positron Emission TomographyFluorodeoxyglucose
Grant awards (93)
Targeting trained immunity in transplantation$3,010,650
P01 · FY2025 · AI · contact PI
Stress-induced immune reprogramming in cardiovascular disease$2,291,978
P01 · FY2025 · HL · contact PI
PET/MRI imaging of mitral valve prolapse$2,047,367
R01 · FY2025 · HL
Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis$823,983
R01 · FY2025 · HL · contact PI
Atherosclerosis in cocaine addiction: imaging risk with PET/MR$752,065
R01 · FY2025 · DA
Multimodal profiling of stress-induced immune reprogramming in cardiovascular patients$683,815
P01 · FY2025 · HL · contact PI
Bioengineering core$569,812
P01 · FY2025 · AI · contact PI
Administrative Core$42,912
P01 · FY2025 · HL · contact PI
Administrative, data management and biostatistics core$32,744
P01 · FY2025 · AI · contact PI
Targeting trained immunity in transplantation$3,018,892
P01 · FY2024 · AI · contact PI
Stress-induced immune reprogramming in cardiovascular disease$2,247,317
P01 · FY2024 · HL · contact PI
PET/MRI imaging of mitral valve prolapse$2,047,367
R01 · FY2024 · HL
Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis$827,356
R01 · FY2024 · HL · contact PI
Atherosclerosis in cocaine addiction: imaging risk with PET/MR$752,116
R01 · FY2024 · DA
Multimodal profiling of stress-induced immune reprogramming in cardiovascular patients$699,151
P01 · FY2024 · HL · contact PI
Bioengineering core$352,710
P01 · FY2024 · AI · contact PI
Administrative Core$54,392
P01 · FY2024 · HL · contact PI
Administrative, data management and biostatistics core$35,106
P01 · FY2024 · AI · contact PI
Targeting trained immunity in transplantation$3,012,041
P01 · FY2023 · AI · contact PI
Stress-induced immune reprogramming in cardiovascular disease$2,346,133
P01 · FY2023 · HL · contact PI
PET/MRI imaging of mitral valve prolapse$2,043,200
R01 · FY2023 · HL
Atherosclerosis in cocaine addiction: imaging risk with PET/MR$752,116
R01 · FY2023 · DA
Multimodal profiling of stress-induced immune reprogramming in cardiovascular patients$730,671
P01 · FY2023 · HL · contact PI
Bioengineering core$320,485
P01 · FY2023 · AI · contact PI
Administrative, data management and biostatistics core$127,743
P01 · FY2023 · AI · contact PI
Administrative Core$55,501
P01 · FY2023 · HL · contact PI
Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI$841,318
R01 · FY2022 · HL · contact PI
Atherosclerosis in cocaine addiction: imaging risk with PET/MR$759,113
R01 · FY2022 · DA
PET nanoreporter image-guided breast cancer therapy$709,571
R01 · FY2022 · CA · contact PI
Stress and Atherosclerotic Plaque Macrophages - A Systems Biology Approach$2,577,339
P01 · FY2021 · HL · contact PI
Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI$841,318
R01 · FY2021 · HL · contact PI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation$815,005
R01 · FY2021 · HL · contact PI
PET nanoreporter image-guided breast cancer therapy$724,053
R01 · FY2021 · CA · contact PI
PET/MRI of the brain-hematopoiesis-atherosclerosis axis in PTSD patients$623,167
P01 · FY2021 · HL · contact PI
Stress and atherosclerotic plaque macrophages - a systems biology approach$169,184
P01 · FY2021 · HL · contact PI
Stress and Atherosclerotic Plaque Macrophages - A Systems Biology Approach$2,576,654
P01 · FY2020 · HL · contact PI
Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI$841,318
R01 · FY2020 · HL · contact PI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation$815,612
R01 · FY2020 · HL · contact PI
Ga68-DOTATATE PET imaging of plaque inflammation$792,197
R01 · FY2020 · HL · contact PI
PET nanoreporter image-guided breast cancer therapy$724,049
R01 · FY2020 · CA · contact PI
PET/MRI of the brain-hematopoiesis-atherosclerosis axis in PTSD patients$623,167
P01 · FY2020 · HL · contact PI
Stress and atherosclerotic plaque macrophages - a systems biology approach$169,184
P01 · FY2020 · HL · contact PI
Stress and Atherosclerotic Plaque Macrophages - A Systems Biology Approach$2,576,655
P01 · FY2019 · HL · contact PI
Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI$841,318
R01 · FY2019 · HL · contact PI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation$816,219
R01 · FY2019 · HL
Ga68-DOTATATE PET imaging of plaque inflammation$703,867
R01 · FY2019 · HL · contact PI
PET/MRI of the brain-hematopoiesis-atherosclerosis axis in PTSD patients$623,167
P01 · FY2019 · HL · contact PI
MR/PET Imaging of coronary atherosclerosis$524,243
R01 · FY2019 · HL · contact PI
Stress and atherosclerotic plaque macrophages - a systems biology approach$169,184
P01 · FY2019 · HL · contact PI
Stress and Atherosclerotic Plaque Macrophages - A Systems Biology Approach$2,576,656
P01 · FY2018 · HL · contact PI
TRAF6 Nanoimmunotherapy to resolve plaque inflammation$851,576
R01 · FY2018 · HL
Ga68-DOTATATE PET imaging of plaque inflammation$666,248
R01 · FY2018 · HL · contact PI
PET/MRI of the brain-hematopoiesis-atherosclerosis axis in PTSD patients$610,702
P01 · FY2018 · HL · contact PI
MR/PET Imaging of coronary atherosclerosis$524,243
R01 · FY2018 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study$463,492
R01 · FY2018 · HL · contact PI
Stress and atherosclerotic plaque macrophages - a systems biology approach$165,801
P01 · FY2018 · HL · contact PI
Stress and Atherosclerotic Plaque Macrophages - A Systems Biology Approach$2,610,896
P01 · FY2017 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study$739,261
R01 · FY2017 · HL · contact PI
Ga68-DOTATATE PET imaging of plaque inflammation$701,991
R01 · FY2017 · HL · contact PI
PET/MRI of the brain-hematopoiesis-atherosclerosis axis in PTSD patients$623,167
P01 · FY2017 · HL · contact PI
MR/PET Imaging of coronary atherosclerosis$524,231
R01 · FY2017 · HL · contact PI
Stress and atherosclerotic plaque macrophages - a systems biology approach$169,184
P01 · FY2017 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study$714,242
R01 · FY2016 · HL · contact PI
MR/PET Imaging of coronary atherosclerosis$524,211
R01 · FY2016 · HL · contact PI
Theranostic HDL nanoparticles for inflammatory macrophages in atherosclerosis$421,221
R01 · FY2016 · EB · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study$670,887
R01 · FY2015 · HL · contact PI
MR/PET Imaging of coronary atherosclerosis$506,204
R01 · FY2015 · HL · contact PI
Theranostic HDL nanoparticles for inflammatory macrophages in atherosclerosis$412,796
R01 · FY2015 · EB · contact PI
In vivo molecular MRI of atherothrombotic lesions$515,583
R01 · FY2014 · HL · contact PI
Theranostic HDL nanoparticles for inflammatory macrophages in atherosclerosis$408,585
R01 · FY2014 · EB · contact PI
In vivo molecular MRI of atherothrombotic lesions$487,879
R01 · FY2013 · HL · contact PI
Theranostic HDL nanoparticles for inflammatory macrophages in atherosclerosis$455,971
R01 · FY2013 · EB · contact PI
Nanoparticles for Molecular MRI of Athersclerosis$73,480
R01 · FY2013 · EB · contact PI
Nanoparticles for Molecular MRI of Atherosclerosis$704,467
R01 · FY2012 · EB · contact PI
In vivo molecular MRI of atherothrombotic lesions$512,209
R01 · FY2012 · HL · contact PI
Nanoparticles for Molecular MRI of Atherosclerosis$705,463
R01 · FY2011 · EB · contact PI
In vivo molecular MRI of atherothrombotic lesions$512,192
R01 · FY2011 · HL · contact PI
Novel Imaging to Predict Cardiovascular Events in Diabetes$817,936
R01 · FY2010 · HL
Nanoparticles for Molecular MRI of Atherosclerosis$714,981
R01 · FY2010 · EB · contact PI
Novel Imaging to Predict Cardiovascular Events in Diabetes$807,360
R01 · FY2009 · HL
Nanoparticles for Molecular MRI of Atherosclerosis$751,228
R01 · FY2009 · EB · contact PI
In Vivo Molecular MRI of Atherothrombotic Lesions$497,339
R01 · FY2009 · HL · contact PI
In Vivo Molecular MRI of Atherothrombotic Lesions$476,914
R01 · FY2008 · HL · contact PI
Nanoparticles for Molecular MRI of Atherosclerosis$91,128
R01 · FY2008 · HL · contact PI
Nanoparticles for Molecular MRI of Atherosclerosis$607,523
R01 · FY2007 · HL · contact PI
In Vivo Molecular MRI of Atherothrombotic Lesions$476,261
R01 · FY2007 · HL · contact PI
Nanoparticles for Molecular MRI of Atherosclerosis$612,266
R01 · FY2006 · HL · contact PI
In Vivo Molecular MRI of Atherothrombotic Lesions$480,109
R01 · FY2006 · HL · contact PI
Nanoparticles for Molecular MRI of Atherosclerosis$613,675
R01 · FY2005 · HL
Nanoparticles for Molecular MRI of Atherosclerosis$614,449
R01 · FY2004 · HL
IN VIVO MOLECULAR MRI OF ATHEROTHROMBOTIC LESIONS$423,750
R01 · FY2004 · HL
IN VIVO MOLECULAR MRI OF ATHEROTHROMBOTIC LESIONS$423,750
R01 · FY2003 · HL
IN VIVO MOLECULAR MRI OF ATHEROTHROMBOTIC LESIONS$423,750
R01 · FY2002 · HL